Dr. Priyanka Jethwani, MD

Dr. Jethwani practices at Avera McKennan Hospital & University Health Center in Sioux Falls, South Dakota, part of Avera Health.

Dr. Jethwani's NPI, 1801247481, was assigned on June 25, 2016. Dr. Jethwani holds Tennessee license 65488.

Dr. Jethwani's primary practice is Avera McKennan Hospital & University Health Center, at 1325 S Cliff Ave Post Office Box 5045, Sioux Falls, SD 57117 in Minnehaha County. The practice phone is (605) 322-8000.

Dr. Jethwani's primary practice is Avera McKennan Hospital & University Health Center in Sioux Falls, South Dakota, part of Avera Health. Dr. Jethwani is also affiliated with Methodist University Hospital. The medical group on file is Avera McKennan Hospital & University Health Center. Dmand AI also links Dr. Jethwani to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jethwani practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Jethwani's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Jethwani is licensed in Tennessee.

CMS data shows 574 Medicare services from Dr. Jethwani across 9 procedure codes in 2024, for 268 Medicare patients. Medicare paid $40,240 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 268 Medicare patients who saw Dr. Jethwani in 2024. The largest group is under 65, with 172 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 33% are also on Medicaid. Their average risk score is 6.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jethwani's median patient age at 58, with 37% women.

In 2024, Dr. Jethwani wrote 2,481 Medicare Part D claims for 329 patients. 89% of them were for generic drugs. CMS names the drug for 2,265 of them, across 40 drugs with 11 or more claims each, at $343,196 in total drug cost. In 2023, CMS named 1,514 claims across 32 drugs.

Dr. Jethwani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Jethwani, published from 2022 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Graft Rejection and Kidney Transplantation. Dr. Jethwani's most frequent co-authors are Arundati Rao and Anushree Chaitanya Shirali, MD.

CMS Open Payments shows 2 general payments to Dr. Jethwani from 2 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $122.